AB260 expands protections for access to medication abortion in California, and shields providers, pharmacists, and facilities from out-of-state interference. It repeals abortion restrictions, updates rules for dispensing mifepristone and similar drugs, and allows pharmacists to dispense them without identifying information to protect privacy. The bill bars criminal, civil, or professional action against anyone lawfully prescribing, supplying, or transporting these medications in California. It also extends until January 31, 2027, the liability exemption for healthcare providers adapting to new abortion privacy rules, and requires insurance plans to cover mifepristone even if used off-label or not FDA-approved, unless a state health risk is declared.
The California State Senate passed AB260 on September 9, 2025 by a vote of 30 to 8. We have assigned pluses to the nays because this bill further entrenches California as a sanctuary for the deliberate taking of innocent human life. By shielding abortionists and drug distributors from accountability, AB260 not only disregards moral law, but also violates the unalienable right to life. The care of human life—not its destruction—is the highest duty of government, yet this legislation treats death as "healthcare," and compels taxpayers to underwrite it. No one has a right to kill a preborn child under the guise of “reproductive freedom,” nor may the state lawfully compel citizens to finance or participate in that evil. The right to life is God-given and affirmed in the Declaration of Independence and the Fifth, Ninth, and 14th Amendments as the first and most essential of all rights upon which liberty itself depends.
